We recently published a list of Billionaire Lei Zhang’s 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against other billionaire Lei Zhang’s stock picks with huge upside potential. Lei Zhang and Hillhouse Capital: Quiet Power in Asian Investing Lei Zhang, the founder and CEO of Hillhouse Capital, is one of the most influential yet low-profile figures in the world of investing. Born and raised in China, Zhang later studied in the US, earning an MBA from Yale, where he was influenced by David Swensen, the university’s legendary endowment manager. It was with Swensen’s support that Zhang launched Hillhouse in 2005, initially backed with capital from Yale’s endowment fund. Hillhouse Capital started small but quickly established itself as a powerhouse in Asia’s fast-evolving markets. The firm is known for its long-term, research-driven approach, often taking significant positions in high-growth companies and partnering with management teams to help scale operations. Rather than chasing short-term gains, Zhang’s strategy is focused on building durable, competitive businesses. One of Hillhouse’s early and most notable investments was in Tencent, the Chinese tech giant. The firm got in when the company was still relatively unknown outside China, and the bet paid off tremendously. Other major holdings have included JD, Baidu, and Meituan, as well as a growing number of companies in sectors like healthcare, logistics, and consumer goods. Zhang’s investment style blends elements of private equity and public market investing. He’s not afraid to hold stakes for many years, and Hillhouse often works closely with portfolio companies to improve operations and governance. This hands-on, collaborative model has helped the firm build a strong reputation among entrepreneurs and institutional investors alike. Hillhouse Capital has since expanded beyond China and now manages tens of billions of dollars across Asia and other markets, with offices in Singapore, Hong Kong, and New York. Despite its size, the firm remains relatively discreet. Zhang himself rarely gives interviews and avoids the spotlight, preferring to let the results speak for themselves. Hillhouse Investment has built a reputation for exceptional returns, achieving annualized gains as high as 52% from its founding through 2012. Its expansion has been fueled by a consistent ability to deliver strong results even as the firm has grown. Hillhouse has a broad sector focus that includes technology and enterprise software. The firm also frequently collaborates with other major investors, such as Sequoia Capital, through co-investment partnerships. Story Continues Under Zhang’s leadership, Hillhouse has become synonymous with disciplined growth investing in some of the world’s most dynamic economies. For many, Zhang represents a new breed of the global investor: one who bridges East and West, and who plays the long game in an increasingly complex financial landscape. Our Methodology For this list, we picked stocks from Hillhouse Capital’s 13F portfolio as of the end of the fourth quarter of 2024. We listed them in the ascending order of analysts’ average upside potential. These equities are also popular among other hedge funds. Note: All data was recorded on May 7, 2025. At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).Danaher Corporation (DHR): Among Billionaire Lei Zhang’s Stock Picks with Huge Upside Potential A healthcare professional in a lab coat holding a microscope and looking at a slide under the lens. Danaher Corporation (NYSE:DHR) Hillhouse Capital’s stake: $3,002,284 Upside Potential: 26.77% Number of Hedge Fund Holders: 101 Danaher Corporation (NYSE:DHR) is a global science and technology company focused on improving human health through its 15+ operating companies in biotechnology, life sciences, and diagnostics. Operating in over 50 countries, Danaher emphasizes recurring revenue, a direct sales model, and the Danaher Business System. Its strategy centers on competitive strength, smart capital allocation, and talent retention. Growth is driven by innovation, acquisitions, and portfolio optimization, with performance measured through financial and non-financial metrics. Danaher Corporation (NYSE:DHR) saw highlighted better-than-expected performance in Q1 2025, driven by strong bioprocessing demand and elevated respiratory diagnostics at Cepheid. Revenue totaled $5.7 billion, with flat core revenue year-over-year. The company emphasized recurring revenue strength, product innovation, and resilience amid global uncertainty in its earnings call. Danaher reaffirmed its 2025 guidance with 3% core revenue growth and adjusted EPS of $7.60–$7.75, leveraging its Danaher Business System and strong financial position to navigate challenges and invest in long-term growth. Danaher reported strong bioprocessing performance, driven by consumables growth and improving equipment demand, leading to a raised 2025 outlook. They expect high-single-digit growth, supported by strong orders and a book-to-bill above one. Tariff impacts, estimated at $350 million, are being offset through pricing actions, manufacturing shifts, and cost savings. Life Sciences guidance was reduced due to US academic and government weakness, though China remains stable outside of VBP pressures. Overall, DHR ranks 7th on our list of billionaire Lei Zhang’s stock picks with huge upside potential. While we acknowledge the potential of DHR as an investment, our conviction lies in the belief that AI stocks hold great promise for delivering high returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than DHR but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires. Disclosure: None. This article is originally published at Insider Monkey.
Danaher Corporation (DHR): Among Billionaire Lei Zhang’s Stock Picks with Huge Upside Potential
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...